Product
VAL-181388
1 clinical trial
1 indication
Indication
Chikungunya VirusClinical trial
A Phase 1, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of VAL-181388 in Healthy Adults in a Non-endemic Chikungunya RegionStatus: Completed, Estimated PCD: 2019-03-19